Breaking News Instant updates and real-time market news.

DCP

DCP Midstream

$32.69

1.46 (4.68%)

, GEL

Genesis Energy

$20.96

0.33 (1.60%)

04:55
01/16/19
01/16
04:55
01/16/19
04:55

UBS to hold a conference

Midstream, MLP & Utilities 1:1 Conference will be held in Park City, Utah on January 14-16.

DCP

DCP Midstream

$32.69

1.46 (4.68%)

GEL

Genesis Energy

$20.96

0.33 (1.60%)

KRP

Kimbell Royalty Partners

$14.97

-0.03 (-0.20%)

PBF

PBF Energy

$34.76

-0.28 (-0.80%)

PBFX

PBF Logistics

$21.22

0.06 (0.28%)

USAC

USA Compression

$14.52

0.01 (0.07%)

OKE

Oneok

$60.95

1.61 (2.71%)

  • 10

    Feb

  • 14

    Feb

  • 14

    Feb

  • 07

    Mar

DCP DCP Midstream
$32.69

1.46 (4.68%)

10/10/18
FBCO
10/10/18
INITIATION
FBCO
Outperform
Credit Suisse bullish on select Oil Midstream stocks on valuation and output
As reported earlier, Credit Suisse analyst Spiro Dounis initiated coverage of 39 midstream oil market stocks, calling DCP Midstream (DCP), Cheniere Energy (LNG), Kinder Morgan (KMI), and MPLX (MPLX) his "top picks". The analyst that his generally "constructive view" is based on expectations of domestic oil and gas production remaining strong as well as his assessment of midstream stocks being "undervalued on several metrics". Dounis adds that he is especially positive on the stocks with leverage to the export market, anticipating "vast majority of marginal production" to clear through the exports. For DCP Midstream, the analyst is positive on the growth project backlog in the DJ and Permian Basin, while for Cheniere Energy, he expects the company's EBITDA and free cash flow generation to ramp up. For Kinder Morgan, Dounis sees a "compelling" capital return story trading at a discount thanks to the company's $6B project backlog expected to drive a 25% distribution growth with an eye on exports.
12/20/18
JEFF
12/20/18
UPGRADE
Target $34
JEFF
Buy
DCP Midstream upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded DCP Midstream to Buy while lowering his price target for the shares to $34 from $44. The analyst finds the Midstream & Refining attractive citing "simplified structures, reduced leverage, minimal equity need, and continued growth." U.S. Midstream and Refining equities are approaching year-end at multi-year lows with valuation multiples 15%-30% below three-year averages, Sighinolfi tells investors in a research note titled "Hey Nineteen, That's Real Opportunity." The analyst sees "supportive" 2019-2020 fundamentals and believes investors will find value in the sector. As such, he upgraded 10 names in the space.
11/20/18
FBCO
11/20/18
NO CHANGE
Target $50
FBCO
Outperform
DCP Midstream price target lowered to $50 from $57 at Credit Suisse
Credit Suisse analyst Spiro Dounis lowered his price target for DCP Midstream to $50 from $57 to reflect what he believes to be a permanent downward re-rating on DJ exposed companies. While Colorado's Prop 112 was defeated this year, investors now appear to be ascribing a higher risk to DJ exposed names where the setback issue could be a recurring event every two years, notwithstanding a permanent solution, he contends. The analyst reiterates an Outperform rating on the shares.
01/10/19
RAJA
01/10/19
INITIATION
Target $36
RAJA
Outperform
DCP Midstream initiated with an Outperform at Raymond James
Raymond James initiated DCP Midstream with an Outperform and $36 price target.
GEL Genesis Energy
$20.96

0.33 (1.60%)

11/02/18
RBCM
11/02/18
UPGRADE
RBCM
Outperform
Genesis Energy upgraded to Outperform from Sector Perform at RBC Capital
09/04/18
BARD
09/04/18
DOWNGRADE
BARD
Neutral
Genesis Energy downgraded to Neutral from Outperform at Baird
11/02/18
RBCM
11/02/18
UPGRADE
Target $29
RBCM
Outperform
Genesis Energy upgraded to Outperform at RBC Capital on cash flow ramp
As reported earlier, RBC Capital analyst TJ Schultz upgraded Genesis Energy to Outperform from Sector Perform and raised his price target to $29 from $26. The analyst notes that Q3 has likely marked an inflection point in terms of generating onshore cash flow growth which coincided with the quarter's "moderate capex". Schultz adds that the combination allows Genesis Energy to "grow distributions, keep healthy coverage, and improve balance sheet".
09/04/18
BARD
09/04/18
DOWNGRADE
Target $26
BARD
Neutral
Genesis Energy downgraded to Neutral at Baird
As reported previously, Baird analyst Ethan Bellamy downgraded Genesis Energy to Neutral from Outperform. The analyst noted the company shaved off some of its leverage ratio with the divestiture of its Powder River Basin property, but he believes the deleveraging pace has slowed and he doesn't expect a valuation move until the leverage recedes meaningfully in 2020. Bellamy maintained his $26 price target on Genesis Energy shares.
KRP Kimbell Royalty Partners
$14.97

-0.03 (-0.20%)

05/11/18
05/11/18
UPGRADE
Target $20

Buy
Kimbell Royalty Partners upgraded to Buy with $20 price target at Stifel
As previously reported, Stifel analyst Timothy Howard upgraded Kimbell Royalty Partners to Buy from Hold, noting that the company announced it is reviewing a potential shift to a federal tax payer from pass through status, which could yield better valuation, liquidity and a broader investor base. Kimbell also reported better than expected Q1 results and elected to sell a small portion of its Permian acreage in an effort to optimize its portfolio, noted Howard, who raised his price target on the units to $20 from $19.
12/07/18
FBCO
12/07/18
INITIATION
Target $21
FBCO
Neutral
Kimbell Royalty Partners initiated with a Neutral at Credit Suisse
Credit Suisse analyst Betty Jiang started Kimbell Royalty Partners with a Neutral rating and $21 price target. The analyst assumes a higher yield target to reflect the company's "below average growth profile and lack of activity visibility."
11/09/18
11/09/18
DOWNGRADE
Target $19

Hold
Kimbell Royalty Partners downgraded to Hold on lower estimates at Stifel
As previously reported, Stifel analyst Timothy Howard downgraded Kimbell Royalty Partners to Hold from Buy after Kimbell missed his production estimate in Q3. He has lowered his production estimates and also expects less accretion on a cash G&A per Boe basis, noted Howard, who also points toward the sharp reduction in crude oil prices since he last updated his model in early October. Given the reduction in his estimates from both lower commodity prices and production, Howard cut his price target on Kimbell shares to $19 from $24, adding that he projects a distribution decline in Q4.
11/09/18
STFL
11/09/18
DOWNGRADE
STFL
Hold
Kimbell Royalty Partners downgraded to Hold from Buy at Stifel
PBF PBF Energy
$34.76

-0.28 (-0.80%)

10/03/18
LEHM
10/03/18
INITIATION
Target $125
LEHM
Overweight
Barclays reinstates Marathon Petroleum at Overweight, names Top Pick
Barclays analyst Paul Cheng reinstated coverage of Marathon Petroleum (MPC) with an Overweight rating and $125 price target. The analyst names Marathon his refining sector's Top Pick, replacing PBF Energy (PBF). With its refining geographic reach spanning coast to coast and consisting of "sufficient critical mass" in each operating region, Marathon is well positioned to benefit whenever a bottleneck is developed, Cheng tells investors in a research note. The analyst believes successful refiners must have the flexibility and capability to take advantage of the country's "increasingly complex and volatile crude differential dynamics as well as the rapidly evolving global crude oil and refined product import and export markets."
10/05/18
FBCO
10/05/18
NO CHANGE
Target $53
FBCO
Neutral
PBF Energy price target raised to $53 from $46 at Credit Suisse
Credit Suisse analyst Manav Gupta raised his price target for PBF Energy to $53 from $46, as he adjusts PBF's Q3 earnings estimate to $1.01 from $1.04 vs. the $1.04 consensus. The analyst reiterates a Neutral rating on the shares, and says PBF's management deserves a lot of credit for stabilizing operations at both Chalmette and Torrance and that the company has come a long way since many questioned the quality of these two assets.
01/10/19
PIPR
01/10/19
INITIATION
Target $43
PIPR
Overweight
PBF Energy assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Blake Fernandez assumed coverage of PBF Energy with an Overweight rating and $43 price target.
01/09/19
MSCO
01/09/19
UPGRADE
MSCO
Overweight
PBF Energy upgraded to Overweight from Equal Weight at Morgan Stanley
PBFX PBF Logistics
$21.22

0.06 (0.28%)

11/06/18
WELS
11/06/18
DOWNGRADE
Target $24
WELS
Market Perform
PBF Logistics downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Praneeth Satish downgraded PBF Logistics to Market Perform and lowered his price target for the shares to $24 from $25. Year-to-date, PBF is up 4.0%, outpacing both the Alerian and the S&P 500, Satish tells investors in a research note. The analyst, however, believes ongoing equity financing needs and a full valuation multiple will limit upside in the shares.
10/10/18
FBCO
10/10/18
INITIATION
Target $24
FBCO
Neutral
PBF Logistics initiated with a Neutral at Credit Suisse
Credit Suisse analyst Spiro Dounis initiated PBF Logistics with a Neutral rating and a price target of $24.
USAC USA Compression
$14.52

0.01 (0.07%)

01/03/19
UBSW
01/03/19
DOWNGRADE
UBSW
Neutral
USA Compression downgraded to Neutral from Buy at UBS
11/07/18
11/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Outperform from Market Perform at Cowen with analyst Oliver Chen saying he believes its combination of strong price value, convenient digitally-enabled pick up options, private brand innovation, and traffic will drive the stock higher. 2. Spark Therapeutics (ONCE) upgraded to Strong Buy from Outperform at Raymond James, to Buy from Neutral at B. Riley FBR, and to Neutral from Underperform at Wedbush. 3. USA Compression (USAC) upgraded to Outperform from Sector Perform at RBC Capital with analyst TJ Schultz saying the company's strong market fundamentals and synergies from its CDM compression acquisition should allow it to de-lever and grow coverage. 4. Noble Energy (NBL) upgraded to Outperform from Market Perform at Raymond James and to Buy from Hold at Tudor Pickering. 5. QEP Resources (QEP) upgraded to Buy from Hold at Tudor Pickering. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/07/18
RBCM
11/07/18
UPGRADE
Target $21
RBCM
Outperform
USA Compression upgraded to Outperform at RBC Capital on CDM integration
RBC Capital analyst TJ Schultz upgraded USA Compression to Outperform from Sector Perform and kept his $21 price target, saying the company's strong market fundamentals and synergies from its CDM compression acquisition should allow it to de-lever and grow coverage. The analyst also expects USA Compression's strong fundamentals to persist through 2019 as it continues to deploy idle fleet to maximize its ROA.
01/03/19
UBSW
01/03/19
DOWNGRADE
Target $12.5
UBSW
Neutral
UBS downgrades USA Compression to Neutral on leverage concerns
UBS analyst Shneur Gershuni downgraded USA Compression Partners to Neutral from Buy and lowered his price target for the shares to $12.50 from $17. Despite the significant increase in rig count and production over the past several years, USA Compression's leverage remains above five times, Gershuni tells investors in a research note. The analyst had expected the company's leverage to improve further than it has as the cycle matured due to higher utilization and revenues per horsepower. Without a significant increase in revenue per horsepower, management will need to wait for cycle improvements with high leverage or take a distribution cut, and either option will likely not be well received by investors, says Gershuni.
OKE Oneok
$60.95

1.61 (2.71%)

01/08/19
JPMS
01/08/19
UPGRADE
Target $74
JPMS
Overweight
Oneok upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeremy Tonet upgraded Oneok to Overweight while lowering his price target for the shares to $74 from $75. The analyst says that while he has have moderated his 2019 EBITDA estimate on a more conservative commodity price outlook, he also increased his 2020 and beyond estimates after factoring in a faster assumed ramp on Belvieu related expansions. Further, Oneok has traded down with commodity prices despite possessing only 5% direct exposure, Tonet tells investors in a research note.
01/08/19
BERN
01/08/19
DOWNGRADE
BERN
Market Perform
Oneok downgraded to Market Perform from Outperform at Bernstein
01/08/19
01/08/19
DOWNGRADE

Market Perform
Oneok downgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst Jean Ann Salisbury downgraded Oneok to Market Perform from Outperform. The analyst notes that oil price has fallen by about 20%, and Oneok has moved down in line with the AMZ index, about 8%. Salisbury believes that the fall in oil price will result in lowering Bakken oil/NGL production for 2019/2020 versus her previous forecast.
01/10/19
RAJA
01/10/19
INITIATION
Target $72
RAJA
Strong Buy
Oneok initiated with a Strong Buy at Raymond James
Raymond James initiated Oneok with a Strong Buy and $72 price target.

TODAY'S FREE FLY STORIES

RTN

Raytheon

$165.11

2.285 (1.40%)

12:33
01/21/19
01/21
12:33
01/21/19
12:33
Hot Stocks
Raytheon awarded $24.36M order for F/A-18 aircraft system repair »

Raytheon said it was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBCP

Independent Bank

$22.80

-0.11 (-0.48%)

11:26
01/21/19
01/21
11:26
01/21/19
11:26
Hot Stocks
Independent Bank boosts quarterly dividend by 20% to 18c »

Independent Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

11:25
01/21/19
01/21
11:25
01/21/19
11:25
General news
FX Update: The dollar majors have been directionally challenged »

FX Update: The dollar…

EDIT

Editas Medicine

$26.16

-0.01 (-0.04%)

11:25
01/21/19
01/21
11:25
01/21/19
11:25
Hot Stocks
Editas Medicine announces publication of EDIT-101 data in Nature Medicine »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

, GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

11:23
01/21/19
01/21
11:23
01/21/19
11:23
Hot Stocks
France's National Data Protection Commission fines Google 50M euros »

France's National…

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

LAD

Lithia Motors

$87.13

1.57 (1.84%)

10:25
01/21/19
01/21
10:25
01/21/19
10:25
Conference/Events
Lithia Motors to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 13

    Feb

  • 14

    Mar

CYDY

CytoDyn

$0.00

(0.00%)

10:25
01/21/19
01/21
10:25
01/21/19
10:25
Conference/Events
CytoDyn participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

ABT

Abbott

$71.43

0.9 (1.28%)

09:50
01/21/19
01/21
09:50
01/21/19
09:50
Hot Stocks
Abbott announces FDA approval of TactiCath Contact Force Ablation Catheter »

Abbott announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Jan

SFUN

Fang Holdings

$1.88

-0.01 (-0.53%)

09:48
01/21/19
01/21
09:48
01/21/19
09:48
Hot Stocks
Fang announces management changes, proposed China Index spin-off »

Fang Holdings announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TS

Tenaris

$24.32

0.64 (2.70%)

09:45
01/21/19
01/21
09:45
01/21/19
09:45
Hot Stocks
Tenaris closes acquisition of 47.79% of Saudi Steel Pipe shares »

Tenaris S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$14.17

-0.31 (-2.14%)

09:42
01/21/19
01/21
09:42
01/21/19
09:42
Hot Stocks
Pan American reports 2018 silver production 24.8M ounces »

Pan American Silver Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWS

Crown Crafts

$5.68

(0.00%)

09:38
01/21/19
01/21
09:38
01/21/19
09:38
Hot Stocks
Crown Crafts announces retirement of NoJo Baby & Kids CEO »

Crown Crafts (CRWS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$37.50

0.6 (1.63%)

, BA

Boeing

$364.79

5.52 (1.54%)

09:36
01/21/19
01/21
09:36
01/21/19
09:36
Hot Stocks
Air Lease announces lease placement of Boeing 737 MAX 9 »

Air Lease (AL) announced…

AL

Air Lease

$37.50

0.6 (1.63%)

BA

Boeing

$364.79

5.52 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 21

    Feb

  • 28

    May

UTSI

UTStarcom

$3.22

0.1 (3.21%)

09:34
01/21/19
01/21
09:34
01/21/19
09:34
Hot Stocks
UTStarcom says TDI paid $4.54 per share to increase stake to 9.9% »

UTStarcom announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$194.63

4.19 (2.20%)

09:31
01/21/19
01/21
09:31
01/21/19
09:31
Hot Stocks
Vertex says European Commission granted label extension for Orkambi »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

ALNY

Alnylam

$83.08

2.4 (2.97%)

09:30
01/21/19
01/21
09:30
01/21/19
09:30
Hot Stocks
Alnylam, Israel's Medison partner to commercialize Onpattro, RNAi portfolio »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$66.56

1.905 (2.95%)

09:26
01/21/19
01/21
09:26
01/21/19
09:26
Hot Stocks
Thor finalizing talks to exclude EHG's North American operations from deal »

Thor Industries provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLWTY

Panalpina

$0.00

(0.00%)

08:44
01/21/19
01/21
08:44
01/21/19
08:44
Downgrade
Panalpina rating change at Jefferies »

Panalpina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFGSY

Eiffage

$0.00

(0.00%)

08:41
01/21/19
01/21
08:41
01/21/19
08:41
Upgrade
Eiffage rating change at Barclays »

Eiffage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVFCF

Television Francaise 1

$0.00

(0.00%)

08:40
01/21/19
01/21
08:40
01/21/19
08:40
Downgrade
Television Francaise 1 rating change at Citi »

Television Francaise 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVDY

Atresmedia

$0.00

(0.00%)

08:37
01/21/19
01/21
08:37
01/21/19
08:37
Upgrade
Atresmedia rating change at Citi »

Atresmedia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDPAY

Tod's

$0.00

(0.00%)

08:36
01/21/19
01/21
08:36
01/21/19
08:36
Downgrade
Tod's rating change at Citi »

Tod's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFRGY

Salvatore Ferragamo

$0.00

(0.00%)

08:35
01/21/19
01/21
08:35
01/21/19
08:35
Downgrade
Salvatore Ferragamo rating change at Citi »

Salvatore Ferragamo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:35
01/21/19
01/21
08:35
01/21/19
08:35
General news
FX Action: USD-CAD has nudged back above 1.3300 »

FX Action: USD-CAD has…

PRDSY

Prada

$0.00

(0.00%)

08:34
01/21/19
01/21
08:34
01/21/19
08:34
Upgrade
Prada rating change at Citi »

Prada upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.